nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefenamic acid—Niflumic Acid—Leflunomide—systemic scleroderma	0.661	1	CrCrCtD
Mefenamic acid—CYP2C8—Mometasone—systemic scleroderma	0.0737	0.541	CbGbCtD
Mefenamic acid—CYP2C9—Leflunomide—systemic scleroderma	0.0331	0.243	CbGbCtD
Mefenamic acid—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0293	0.215	CbGbCtD
Mefenamic acid—CYP2C9—cardial valve—systemic scleroderma	0.01	0.343	CbGeAlD
Mefenamic acid—PTGS2—skeletal joint—systemic scleroderma	0.00314	0.107	CbGeAlD
Mefenamic acid—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.00143	0.624	CbGdCrCtD
Mefenamic acid—AKR1C3—smooth muscle tissue—systemic scleroderma	0.00142	0.0485	CbGeAlD
Mefenamic acid—PTGS1—artery—systemic scleroderma	0.00138	0.047	CbGeAlD
Mefenamic acid—PTGS2—artery—systemic scleroderma	0.00132	0.0449	CbGeAlD
Mefenamic acid—PTGS1—endothelium—systemic scleroderma	0.00116	0.0397	CbGeAlD
Mefenamic acid—PTGS2—endothelium—systemic scleroderma	0.00111	0.0379	CbGeAlD
Mefenamic acid—PTGS1—blood vessel—systemic scleroderma	0.00107	0.0366	CbGeAlD
Mefenamic acid—AKR1C3—tendon—systemic scleroderma	0.00107	0.0364	CbGeAlD
Mefenamic acid—PTGS2—blood vessel—systemic scleroderma	0.00102	0.035	CbGeAlD
Mefenamic acid—AKR1C3—lung—systemic scleroderma	0.000937	0.032	CbGeAlD
Mefenamic acid—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000864	0.376	CbGdCrCtD
Mefenamic acid—PTGS1—connective tissue—systemic scleroderma	0.00055	0.0188	CbGeAlD
Mefenamic acid—PTGS2—connective tissue—systemic scleroderma	0.000525	0.0179	CbGeAlD
Mefenamic acid—PTGS1—smooth muscle tissue—systemic scleroderma	0.000503	0.0172	CbGeAlD
Mefenamic acid—PTGS1—skin of body—systemic scleroderma	0.000496	0.0169	CbGeAlD
Mefenamic acid—PTGS2—smooth muscle tissue—systemic scleroderma	0.000481	0.0164	CbGeAlD
Mefenamic acid—PTGS2—skin of body—systemic scleroderma	0.000474	0.0162	CbGeAlD
Mefenamic acid—CYP2C9—digestive system—systemic scleroderma	0.000435	0.0148	CbGeAlD
Mefenamic acid—PTGS1—digestive system—systemic scleroderma	0.000397	0.0135	CbGeAlD
Mefenamic acid—PTGS2—digestive system—systemic scleroderma	0.000379	0.013	CbGeAlD
Mefenamic acid—PTGS1—tendon—systemic scleroderma	0.000378	0.0129	CbGeAlD
Mefenamic acid—PTGS2—tendon—systemic scleroderma	0.000361	0.0123	CbGeAlD
Mefenamic acid—PTGS1—lung—systemic scleroderma	0.000332	0.0113	CbGeAlD
Mefenamic acid—PTGS2—lung—systemic scleroderma	0.000317	0.0108	CbGeAlD
Mefenamic acid—Asthenia—Captopril—systemic scleroderma	0.000146	0.00085	CcSEcCtD
Mefenamic acid—Dermatitis—Mometasone—systemic scleroderma	0.000145	0.000849	CcSEcCtD
Mefenamic acid—Decreased appetite—Leflunomide—systemic scleroderma	0.000145	0.000848	CcSEcCtD
Mefenamic acid—Confusional state—Lisinopril—systemic scleroderma	0.000145	0.000846	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000145	0.000845	CcSEcCtD
Mefenamic acid—Headache—Mometasone—systemic scleroderma	0.000145	0.000845	CcSEcCtD
Mefenamic acid—Tremor—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000844	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000144	0.000843	CcSEcCtD
Mefenamic acid—Insomnia—Mycophenolic acid—systemic scleroderma	0.000144	0.000842	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000144	0.000839	CcSEcCtD
Mefenamic acid—Oedema—Lisinopril—systemic scleroderma	0.000144	0.000839	CcSEcCtD
Mefenamic acid—Pruritus—Captopril—systemic scleroderma	0.000144	0.000838	CcSEcCtD
Mefenamic acid—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000143	0.000836	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000835	CcSEcCtD
Mefenamic acid—Constipation—Leflunomide—systemic scleroderma	0.000143	0.000835	CcSEcCtD
Mefenamic acid—Infection—Lisinopril—systemic scleroderma	0.000143	0.000833	CcSEcCtD
Mefenamic acid—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000832	CcSEcCtD
Mefenamic acid—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000142	0.00083	CcSEcCtD
Mefenamic acid—Somnolence—Mycophenolic acid—systemic scleroderma	0.000142	0.000828	CcSEcCtD
Mefenamic acid—Shock—Lisinopril—systemic scleroderma	0.000141	0.000825	CcSEcCtD
Mefenamic acid—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000823	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000141	0.000821	CcSEcCtD
Mefenamic acid—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00014	0.00082	CcSEcCtD
Mefenamic acid—Tachycardia—Lisinopril—systemic scleroderma	0.00014	0.000819	CcSEcCtD
Mefenamic acid—Body temperature increased—Azathioprine—systemic scleroderma	0.00014	0.000817	CcSEcCtD
Mefenamic acid—Abdominal pain—Azathioprine—systemic scleroderma	0.00014	0.000817	CcSEcCtD
Mefenamic acid—Skin disorder—Lisinopril—systemic scleroderma	0.00014	0.000815	CcSEcCtD
Mefenamic acid—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000812	CcSEcCtD
Mefenamic acid—Diarrhoea—Captopril—systemic scleroderma	0.000139	0.00081	CcSEcCtD
Mefenamic acid—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000139	0.000809	CcSEcCtD
Mefenamic acid—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000809	CcSEcCtD
Mefenamic acid—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000807	CcSEcCtD
Mefenamic acid—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000806	CcSEcCtD
Mefenamic acid—Feeling abnormal—Leflunomide—systemic scleroderma	0.000138	0.000804	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000138	0.000804	CcSEcCtD
Mefenamic acid—Nausea—Mometasone—systemic scleroderma	0.000137	0.000801	CcSEcCtD
Mefenamic acid—Anorexia—Lisinopril—systemic scleroderma	0.000137	0.000799	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000137	0.000798	CcSEcCtD
Mefenamic acid—Constipation—Mycophenolic acid—systemic scleroderma	0.000136	0.000796	CcSEcCtD
Mefenamic acid—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000796	CcSEcCtD
Mefenamic acid—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000791	CcSEcCtD
Mefenamic acid—Hyperglycaemia—Prednisone—systemic scleroderma	0.000135	0.00079	CcSEcCtD
Mefenamic acid—Hypotension—Lisinopril—systemic scleroderma	0.000134	0.000784	CcSEcCtD
Mefenamic acid—Dizziness—Captopril—systemic scleroderma	0.000134	0.000783	CcSEcCtD
Mefenamic acid—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000134	0.000782	CcSEcCtD
Mefenamic acid—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000134	0.00078	CcSEcCtD
Mefenamic acid—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000777	CcSEcCtD
Mefenamic acid—Urticaria—Leflunomide—systemic scleroderma	0.000133	0.000775	CcSEcCtD
Mefenamic acid—Abdominal pain—Leflunomide—systemic scleroderma	0.000132	0.000772	CcSEcCtD
Mefenamic acid—Body temperature increased—Leflunomide—systemic scleroderma	0.000132	0.000772	CcSEcCtD
Mefenamic acid—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000132	0.00077	CcSEcCtD
Mefenamic acid—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000131	0.000767	CcSEcCtD
Mefenamic acid—Myocardial infarction—Prednisone—systemic scleroderma	0.000131	0.000766	CcSEcCtD
Mefenamic acid—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000131	0.000764	CcSEcCtD
Mefenamic acid—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000131	0.000763	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00013	0.000761	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000761	CcSEcCtD
Mefenamic acid—Insomnia—Lisinopril—systemic scleroderma	0.00013	0.000759	CcSEcCtD
Mefenamic acid—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000757	CcSEcCtD
Mefenamic acid—Paraesthesia—Lisinopril—systemic scleroderma	0.000129	0.000753	CcSEcCtD
Mefenamic acid—Vomiting—Captopril—systemic scleroderma	0.000129	0.000753	CcSEcCtD
Mefenamic acid—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000128	0.00075	CcSEcCtD
Mefenamic acid—Dyspnoea—Lisinopril—systemic scleroderma	0.000128	0.000748	CcSEcCtD
Mefenamic acid—Rash—Captopril—systemic scleroderma	0.000128	0.000747	CcSEcCtD
Mefenamic acid—Dermatitis—Captopril—systemic scleroderma	0.000128	0.000746	CcSEcCtD
Mefenamic acid—Somnolence—Lisinopril—systemic scleroderma	0.000128	0.000746	CcSEcCtD
Mefenamic acid—Headache—Captopril—systemic scleroderma	0.000127	0.000742	CcSEcCtD
Mefenamic acid—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000741	CcSEcCtD
Mefenamic acid—Dyspepsia—Lisinopril—systemic scleroderma	0.000126	0.000738	CcSEcCtD
Mefenamic acid—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000126	0.000736	CcSEcCtD
Mefenamic acid—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000126	0.000736	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000735	CcSEcCtD
Mefenamic acid—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000735	CcSEcCtD
Mefenamic acid—Asthma—Methotrexate—systemic scleroderma	0.000125	0.000732	CcSEcCtD
Mefenamic acid—Infection—Mycophenolate mofetil—systemic scleroderma	0.000125	0.00073	CcSEcCtD
Mefenamic acid—Decreased appetite—Lisinopril—systemic scleroderma	0.000125	0.000729	CcSEcCtD
Mefenamic acid—Eosinophilia—Methotrexate—systemic scleroderma	0.000124	0.000725	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000124	0.000724	CcSEcCtD
Mefenamic acid—Shock—Mycophenolate mofetil—systemic scleroderma	0.000124	0.000723	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000719	CcSEcCtD
Mefenamic acid—Pancreatitis—Methotrexate—systemic scleroderma	0.000123	0.000718	CcSEcCtD
Mefenamic acid—Constipation—Lisinopril—systemic scleroderma	0.000123	0.000717	CcSEcCtD
Mefenamic acid—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000717	CcSEcCtD
Mefenamic acid—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000714	CcSEcCtD
Mefenamic acid—Diarrhoea—Azathioprine—systemic scleroderma	0.000121	0.000707	CcSEcCtD
Mefenamic acid—Haemoglobin—Prednisone—systemic scleroderma	0.000121	0.000705	CcSEcCtD
Mefenamic acid—Nausea—Captopril—systemic scleroderma	0.00012	0.000703	CcSEcCtD
Mefenamic acid—Haemorrhage—Prednisone—systemic scleroderma	0.00012	0.000701	CcSEcCtD
Mefenamic acid—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.00012	0.0007	CcSEcCtD
Mefenamic acid—Asthenia—Leflunomide—systemic scleroderma	0.00012	0.0007	CcSEcCtD
Mefenamic acid—Hallucination—Prednisone—systemic scleroderma	0.000119	0.000698	CcSEcCtD
Mefenamic acid—Pancytopenia—Methotrexate—systemic scleroderma	0.000119	0.000695	CcSEcCtD
Mefenamic acid—Feeling abnormal—Lisinopril—systemic scleroderma	0.000118	0.000691	CcSEcCtD
Mefenamic acid—Pruritus—Leflunomide—systemic scleroderma	0.000118	0.000691	CcSEcCtD
Mefenamic acid—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000118	0.000687	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000117	0.000686	CcSEcCtD
Mefenamic acid—Dysuria—Methotrexate—systemic scleroderma	0.000117	0.000685	CcSEcCtD
Mefenamic acid—Dizziness—Azathioprine—systemic scleroderma	0.000117	0.000683	CcSEcCtD
Mefenamic acid—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000114	0.000668	CcSEcCtD
Mefenamic acid—Asthenia—Mycophenolic acid—systemic scleroderma	0.000114	0.000668	CcSEcCtD
Mefenamic acid—Diarrhoea—Leflunomide—systemic scleroderma	0.000114	0.000668	CcSEcCtD
Mefenamic acid—Urticaria—Lisinopril—systemic scleroderma	0.000114	0.000666	CcSEcCtD
Mefenamic acid—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000665	CcSEcCtD
Mefenamic acid—Abdominal pain—Lisinopril—systemic scleroderma	0.000114	0.000663	CcSEcCtD
Mefenamic acid—Body temperature increased—Lisinopril—systemic scleroderma	0.000114	0.000663	CcSEcCtD
Mefenamic acid—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000113	0.00066	CcSEcCtD
Mefenamic acid—Pruritus—Mycophenolic acid—systemic scleroderma	0.000113	0.000659	CcSEcCtD
Mefenamic acid—Vomiting—Azathioprine—systemic scleroderma	0.000113	0.000657	CcSEcCtD
Mefenamic acid—Pneumonia—Methotrexate—systemic scleroderma	0.000112	0.000656	CcSEcCtD
Mefenamic acid—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000655	CcSEcCtD
Mefenamic acid—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000653	CcSEcCtD
Mefenamic acid—Drowsiness—Methotrexate—systemic scleroderma	0.000112	0.000653	CcSEcCtD
Mefenamic acid—Rash—Azathioprine—systemic scleroderma	0.000112	0.000652	CcSEcCtD
Mefenamic acid—Dermatitis—Azathioprine—systemic scleroderma	0.000112	0.000651	CcSEcCtD
Mefenamic acid—Headache—Azathioprine—systemic scleroderma	0.000111	0.000647	CcSEcCtD
Mefenamic acid—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000111	0.000647	CcSEcCtD
Mefenamic acid—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000647	CcSEcCtD
Mefenamic acid—Dizziness—Leflunomide—systemic scleroderma	0.000111	0.000645	CcSEcCtD
Mefenamic acid—Renal failure—Methotrexate—systemic scleroderma	0.00011	0.000642	CcSEcCtD
Mefenamic acid—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000639	CcSEcCtD
Mefenamic acid—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000109	0.000637	CcSEcCtD
Mefenamic acid—Stomatitis—Methotrexate—systemic scleroderma	0.000109	0.000636	CcSEcCtD
Mefenamic acid—Conjunctivitis—Methotrexate—systemic scleroderma	0.000109	0.000634	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000634	CcSEcCtD
Mefenamic acid—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000628	CcSEcCtD
Mefenamic acid—Arrhythmia—Prednisone—systemic scleroderma	0.000107	0.000626	CcSEcCtD
Mefenamic acid—Haematuria—Methotrexate—systemic scleroderma	0.000107	0.000622	CcSEcCtD
Mefenamic acid—Vomiting—Leflunomide—systemic scleroderma	0.000106	0.000621	CcSEcCtD
Mefenamic acid—Alopecia—Prednisone—systemic scleroderma	0.000106	0.00062	CcSEcCtD
Mefenamic acid—Dizziness—Mycophenolic acid—systemic scleroderma	0.000105	0.000616	CcSEcCtD
Mefenamic acid—Rash—Leflunomide—systemic scleroderma	0.000105	0.000615	CcSEcCtD
Mefenamic acid—Dermatitis—Leflunomide—systemic scleroderma	0.000105	0.000615	CcSEcCtD
Mefenamic acid—Mental disorder—Prednisone—systemic scleroderma	0.000105	0.000614	CcSEcCtD
Mefenamic acid—Nausea—Azathioprine—systemic scleroderma	0.000105	0.000614	CcSEcCtD
Mefenamic acid—Headache—Leflunomide—systemic scleroderma	0.000105	0.000611	CcSEcCtD
Mefenamic acid—Agranulocytosis—Methotrexate—systemic scleroderma	0.000104	0.000609	CcSEcCtD
Mefenamic acid—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000606	CcSEcCtD
Mefenamic acid—Asthenia—Lisinopril—systemic scleroderma	0.000103	0.000602	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000601	CcSEcCtD
Mefenamic acid—Pruritus—Lisinopril—systemic scleroderma	0.000102	0.000593	CcSEcCtD
Mefenamic acid—Vomiting—Mycophenolic acid—systemic scleroderma	0.000101	0.000592	CcSEcCtD
Mefenamic acid—Haemoglobin—Methotrexate—systemic scleroderma	0.000101	0.000589	CcSEcCtD
Mefenamic acid—Rash—Mycophenolic acid—systemic scleroderma	0.000101	0.000587	CcSEcCtD
Mefenamic acid—Dermatitis—Mycophenolic acid—systemic scleroderma	0.0001	0.000587	CcSEcCtD
Mefenamic acid—Haemorrhage—Methotrexate—systemic scleroderma	0.0001	0.000586	CcSEcCtD
Mefenamic acid—Hepatitis—Methotrexate—systemic scleroderma	0.0001	0.000586	CcSEcCtD
Mefenamic acid—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.0001	0.000584	CcSEcCtD
Mefenamic acid—Headache—Mycophenolic acid—systemic scleroderma	9.99e-05	0.000583	CcSEcCtD
Mefenamic acid—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	9.95e-05	0.000581	CcSEcCtD
Mefenamic acid—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	9.95e-05	0.000581	CcSEcCtD
Mefenamic acid—Nausea—Leflunomide—systemic scleroderma	9.93e-05	0.00058	CcSEcCtD
Mefenamic acid—Urinary tract disorder—Methotrexate—systemic scleroderma	9.91e-05	0.000579	CcSEcCtD
Mefenamic acid—Vision blurred—Prednisone—systemic scleroderma	9.85e-05	0.000575	CcSEcCtD
Mefenamic acid—Urethral disorder—Methotrexate—systemic scleroderma	9.84e-05	0.000574	CcSEcCtD
Mefenamic acid—Diarrhoea—Lisinopril—systemic scleroderma	9.83e-05	0.000574	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Prednisone—systemic scleroderma	9.7e-05	0.000566	CcSEcCtD
Mefenamic acid—Anaemia—Prednisone—systemic scleroderma	9.66e-05	0.000564	CcSEcCtD
Mefenamic acid—Angioedema—Prednisone—systemic scleroderma	9.55e-05	0.000558	CcSEcCtD
Mefenamic acid—Dizziness—Lisinopril—systemic scleroderma	9.5e-05	0.000555	CcSEcCtD
Mefenamic acid—Erythema multiforme—Methotrexate—systemic scleroderma	9.49e-05	0.000554	CcSEcCtD
Mefenamic acid—Nausea—Mycophenolic acid—systemic scleroderma	9.47e-05	0.000553	CcSEcCtD
Mefenamic acid—Malaise—Prednisone—systemic scleroderma	9.43e-05	0.00055	CcSEcCtD
Mefenamic acid—Vertigo—Prednisone—systemic scleroderma	9.39e-05	0.000548	CcSEcCtD
Mefenamic acid—Syncope—Prednisone—systemic scleroderma	9.37e-05	0.000547	CcSEcCtD
Mefenamic acid—Tinnitus—Methotrexate—systemic scleroderma	9.36e-05	0.000546	CcSEcCtD
Mefenamic acid—Loss of consciousness—Prednisone—systemic scleroderma	9.19e-05	0.000536	CcSEcCtD
Mefenamic acid—Vomiting—Lisinopril—systemic scleroderma	9.13e-05	0.000533	CcSEcCtD
Mefenamic acid—Rash—Lisinopril—systemic scleroderma	9.06e-05	0.000529	CcSEcCtD
Mefenamic acid—Convulsion—Prednisone—systemic scleroderma	9.06e-05	0.000529	CcSEcCtD
Mefenamic acid—Dermatitis—Lisinopril—systemic scleroderma	9.05e-05	0.000528	CcSEcCtD
Mefenamic acid—Asthenia—Mycophenolate mofetil—systemic scleroderma	9.03e-05	0.000527	CcSEcCtD
Mefenamic acid—Hypertension—Prednisone—systemic scleroderma	9.03e-05	0.000527	CcSEcCtD
Mefenamic acid—Headache—Lisinopril—systemic scleroderma	9e-05	0.000525	CcSEcCtD
Mefenamic acid—Pruritus—Mycophenolate mofetil—systemic scleroderma	8.9e-05	0.00052	CcSEcCtD
Mefenamic acid—Anxiety—Prednisone—systemic scleroderma	8.87e-05	0.000518	CcSEcCtD
Mefenamic acid—Alopecia—Methotrexate—systemic scleroderma	8.87e-05	0.000518	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	8.84e-05	0.000516	CcSEcCtD
Mefenamic acid—Discomfort—Prednisone—systemic scleroderma	8.79e-05	0.000513	CcSEcCtD
Mefenamic acid—Mental disorder—Methotrexate—systemic scleroderma	8.79e-05	0.000513	CcSEcCtD
Mefenamic acid—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	8.61e-05	0.000503	CcSEcCtD
Mefenamic acid—Nausea—Lisinopril—systemic scleroderma	8.53e-05	0.000498	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Prednisone—systemic scleroderma	8.53e-05	0.000498	CcSEcCtD
Mefenamic acid—Oedema—Prednisone—systemic scleroderma	8.53e-05	0.000498	CcSEcCtD
Mefenamic acid—Infection—Prednisone—systemic scleroderma	8.48e-05	0.000495	CcSEcCtD
Mefenamic acid—Shock—Prednisone—systemic scleroderma	8.39e-05	0.00049	CcSEcCtD
Mefenamic acid—Tachycardia—Prednisone—systemic scleroderma	8.33e-05	0.000486	CcSEcCtD
Mefenamic acid—Dizziness—Mycophenolate mofetil—systemic scleroderma	8.32e-05	0.000486	CcSEcCtD
Mefenamic acid—Skin disorder—Prednisone—systemic scleroderma	8.29e-05	0.000484	CcSEcCtD
Mefenamic acid—Vision blurred—Methotrexate—systemic scleroderma	8.23e-05	0.000481	CcSEcCtD
Mefenamic acid—Anorexia—Prednisone—systemic scleroderma	8.13e-05	0.000475	CcSEcCtD
Mefenamic acid—Ill-defined disorder—Methotrexate—systemic scleroderma	8.11e-05	0.000473	CcSEcCtD
Mefenamic acid—Anaemia—Methotrexate—systemic scleroderma	8.07e-05	0.000471	CcSEcCtD
Mefenamic acid—Vomiting—Mycophenolate mofetil—systemic scleroderma	8e-05	0.000467	CcSEcCtD
Mefenamic acid—Rash—Mycophenolate mofetil—systemic scleroderma	7.94e-05	0.000463	CcSEcCtD
Mefenamic acid—Dermatitis—Mycophenolate mofetil—systemic scleroderma	7.93e-05	0.000463	CcSEcCtD
Mefenamic acid—Headache—Mycophenolate mofetil—systemic scleroderma	7.88e-05	0.00046	CcSEcCtD
Mefenamic acid—Malaise—Methotrexate—systemic scleroderma	7.88e-05	0.00046	CcSEcCtD
Mefenamic acid—Vertigo—Methotrexate—systemic scleroderma	7.85e-05	0.000458	CcSEcCtD
Mefenamic acid—Leukopenia—Methotrexate—systemic scleroderma	7.82e-05	0.000457	CcSEcCtD
Mefenamic acid—Insomnia—Prednisone—systemic scleroderma	7.72e-05	0.000451	CcSEcCtD
Mefenamic acid—Paraesthesia—Prednisone—systemic scleroderma	7.66e-05	0.000447	CcSEcCtD
Mefenamic acid—Convulsion—Methotrexate—systemic scleroderma	7.57e-05	0.000442	CcSEcCtD
Mefenamic acid—Dyspepsia—Prednisone—systemic scleroderma	7.51e-05	0.000438	CcSEcCtD
Mefenamic acid—Nausea—Mycophenolate mofetil—systemic scleroderma	7.48e-05	0.000436	CcSEcCtD
Mefenamic acid—Decreased appetite—Prednisone—systemic scleroderma	7.42e-05	0.000433	CcSEcCtD
Mefenamic acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	7.39e-05	0.000431	CcSEcCtD
Mefenamic acid—Discomfort—Methotrexate—systemic scleroderma	7.35e-05	0.000429	CcSEcCtD
Mefenamic acid—Constipation—Prednisone—systemic scleroderma	7.3e-05	0.000426	CcSEcCtD
Mefenamic acid—Confusional state—Methotrexate—systemic scleroderma	7.19e-05	0.00042	CcSEcCtD
Mefenamic acid—Anaphylactic shock—Methotrexate—systemic scleroderma	7.13e-05	0.000416	CcSEcCtD
Mefenamic acid—Infection—Methotrexate—systemic scleroderma	7.08e-05	0.000414	CcSEcCtD
Mefenamic acid—Feeling abnormal—Prednisone—systemic scleroderma	7.03e-05	0.00041	CcSEcCtD
Mefenamic acid—Thrombocytopenia—Methotrexate—systemic scleroderma	6.98e-05	0.000408	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Prednisone—systemic scleroderma	6.98e-05	0.000407	CcSEcCtD
Mefenamic acid—Skin disorder—Methotrexate—systemic scleroderma	6.93e-05	0.000404	CcSEcCtD
Mefenamic acid—Anorexia—Methotrexate—systemic scleroderma	6.8e-05	0.000397	CcSEcCtD
Mefenamic acid—Urticaria—Prednisone—systemic scleroderma	6.78e-05	0.000396	CcSEcCtD
Mefenamic acid—Abdominal pain—Prednisone—systemic scleroderma	6.74e-05	0.000394	CcSEcCtD
Mefenamic acid—Body temperature increased—Prednisone—systemic scleroderma	6.74e-05	0.000394	CcSEcCtD
Mefenamic acid—Hypotension—Methotrexate—systemic scleroderma	6.66e-05	0.000389	CcSEcCtD
Mefenamic acid—Insomnia—Methotrexate—systemic scleroderma	6.45e-05	0.000377	CcSEcCtD
Mefenamic acid—Paraesthesia—Methotrexate—systemic scleroderma	6.4e-05	0.000374	CcSEcCtD
Mefenamic acid—Dyspnoea—Methotrexate—systemic scleroderma	6.36e-05	0.000371	CcSEcCtD
Mefenamic acid—Somnolence—Methotrexate—systemic scleroderma	6.34e-05	0.00037	CcSEcCtD
Mefenamic acid—Dyspepsia—Methotrexate—systemic scleroderma	6.28e-05	0.000366	CcSEcCtD
Mefenamic acid—Decreased appetite—Methotrexate—systemic scleroderma	6.2e-05	0.000362	CcSEcCtD
Mefenamic acid—Gastrointestinal disorder—Methotrexate—systemic scleroderma	6.16e-05	0.000359	CcSEcCtD
Mefenamic acid—Asthenia—Prednisone—systemic scleroderma	6.12e-05	0.000357	CcSEcCtD
Mefenamic acid—Pruritus—Prednisone—systemic scleroderma	6.04e-05	0.000352	CcSEcCtD
Mefenamic acid—Feeling abnormal—Methotrexate—systemic scleroderma	5.88e-05	0.000343	CcSEcCtD
Mefenamic acid—Diarrhoea—Prednisone—systemic scleroderma	5.84e-05	0.000341	CcSEcCtD
Mefenamic acid—Gastrointestinal pain—Methotrexate—systemic scleroderma	5.83e-05	0.00034	CcSEcCtD
Mefenamic acid—Urticaria—Methotrexate—systemic scleroderma	5.66e-05	0.000331	CcSEcCtD
Mefenamic acid—Dizziness—Prednisone—systemic scleroderma	5.64e-05	0.000329	CcSEcCtD
Mefenamic acid—Abdominal pain—Methotrexate—systemic scleroderma	5.64e-05	0.000329	CcSEcCtD
Mefenamic acid—Body temperature increased—Methotrexate—systemic scleroderma	5.64e-05	0.000329	CcSEcCtD
Mefenamic acid—Vomiting—Prednisone—systemic scleroderma	5.42e-05	0.000317	CcSEcCtD
Mefenamic acid—Rash—Prednisone—systemic scleroderma	5.38e-05	0.000314	CcSEcCtD
Mefenamic acid—Dermatitis—Prednisone—systemic scleroderma	5.37e-05	0.000314	CcSEcCtD
Mefenamic acid—Headache—Prednisone—systemic scleroderma	5.34e-05	0.000312	CcSEcCtD
Mefenamic acid—Asthenia—Methotrexate—systemic scleroderma	5.12e-05	0.000299	CcSEcCtD
Mefenamic acid—Nausea—Prednisone—systemic scleroderma	5.07e-05	0.000296	CcSEcCtD
Mefenamic acid—Pruritus—Methotrexate—systemic scleroderma	5.04e-05	0.000295	CcSEcCtD
Mefenamic acid—Diarrhoea—Methotrexate—systemic scleroderma	4.88e-05	0.000285	CcSEcCtD
Mefenamic acid—Dizziness—Methotrexate—systemic scleroderma	4.71e-05	0.000275	CcSEcCtD
Mefenamic acid—Vomiting—Methotrexate—systemic scleroderma	4.53e-05	0.000265	CcSEcCtD
Mefenamic acid—Rash—Methotrexate—systemic scleroderma	4.5e-05	0.000262	CcSEcCtD
Mefenamic acid—Dermatitis—Methotrexate—systemic scleroderma	4.49e-05	0.000262	CcSEcCtD
Mefenamic acid—Headache—Methotrexate—systemic scleroderma	4.47e-05	0.000261	CcSEcCtD
Mefenamic acid—Nausea—Methotrexate—systemic scleroderma	4.24e-05	0.000247	CcSEcCtD
